glp-1 ro.co Ro launches the Insurance Coverage Checker “I can make it to

Description

Read more about our research collaboration here: | 11 comments on LinkedIn

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy two days after it announced the new drug and one day after the Food and Drug Administration threatened to restrict access to t

Individuals should consult their clinicians regarding diagnosis or treatment decisions

COVID-19 can complicate GLP-1 weight loss therapy, but recent research shows semaglutide remains safe for most patients who maintain hydration and monitor symptoms during acute illness

In this review, we summarize the state-of-the-art evidence regarding the epidemiology and pathophysiology of diabetic HFpEF, and the landscape of the novel antidiabetic drugs in the treatment of diabetic HFpEF, as well as discuss the relevant mechanisms, aiming to broaden the understanding of diabetic HFpEF and gain new insight into the treatment of this disease